4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-12-001892
Options or other derivatives
- CFO, TREASURER AND SECRETARY acquired 863,511 shares (grant or award)
- CFO, TREASURER AND SECRETARY returned 1,387,512 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Varvaro Thomas C · CFO, TREASURER AND SECRETARY
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-12-21 | Returned to the company : show line 1 in the form Employee Stock Options (right to buy) | −645,900 | $1.55 | 2020-05-20 | 645,900 | 2,032,600 | D |
| 2012-12-21 | Returned to the company : show line 2 in the form Employee Stock Options (right to buy) | −645,900 | $1.55 | 2020-05-20 | 645,900 | 1,386,700 | D |
| 2012-12-21 | Returned to the company : show line 3 in the form Employee Stock Options (right to buy) | −95,712 | $1.54 | 2021-05-10 | 95,712 | 1,290,988 | D |
| 2012-12-21 | Grant or award : show line 4 in the form Employee Stock Options (right to buy) | +863,511 | $0.95 | 2022-09-15 | 863,511 | 2,154,499 | D |
Loading xslF345X03/form4-12212012_041221.xml…